Clinical Trials
YS Biopharma's New HBV Vaccine Gains Clinical Trial Approval in the Philippines
YS Biopharma, a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therap...
April 19, 2024 | News
Cognivia Secures Strategic Investment to Revolutionize Clinical Trials with AI
Cognivia, an innovative AI company dedicated to reshaping pharmaceutical and biotech clinical research through cutting edge AI-ML algorithms, proudly annou...
April 19, 2024 | News
Artiva Biotherapeutics Initiates First U.S. Trial of Allogeneic NK Cell Therapy for Lupus Nephritis
Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-bas...
April 18, 2024 | News
Actinogen Medical Launches Phase 2b XanaMIA Trial for Alzheimer's, Marks First Patient Treatment
Actinogen Medical Limited (ASX: ACW) announces that the first patient has been randomized and treated in the XanaMIA phase 2b clin...
April 16, 2024 | News
Singapore-Based Respiree Expands to U.S., Establishes Presence at Johnson & Johnson Innovation Hub in South San Francisco
Respiree announced that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @ South San Francis...
April 16, 2024 | News
Teva Validates AJOVY® Efficacy and Safety in China Phase 3 Migraine Trial
AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significanc...
April 15, 2024 | News
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
These findings build upon the compelling clinical activity demonstrated by BOT/BAL across nine different cancer types in Agenus' broad clinical dev...
April 13, 2024 | News
Kexing Biopharm Advances Pediatric Care with Phase III Trial of Novel RSV Inhalation Therapy
Kexing Biopharm (688136.SH) announced that the Phase III clinical trial of Human Interferon α1b Inhalation Solution developed by its wholly-owned sub...
April 11, 2024 | News
BioCity Biopharma's Cancer Therapy BC2027 Gets FDA Nod for Phase 1 Trials
BioCity Biopharma announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a Pha...
April 10, 2024 | News
Dizal's Sunvozertinib Secures FDA Breakthrough Therapy Designation for First-Line EGFR Mutated NSCLC Treatment
Dizal announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation (BTD) to its sunvozertinib as the firs...
April 08, 2024 | News
Ractigen Therapeutics Launches Pioneering Phase I Clinical Trial for Bladder Cancer with First Patient Dosed in Collaboration with GenesisCare
Ractigen Therapeutics, a pioneer in small activating RNA (saRNA) therapeutics, achieved a major milestone with the first patient dosed in its First-in-huma...
April 04, 2024 | News
YolTech Therapeutics Initiates Clinical Trial for Gene Editing Treatment YOLT-101 Targeting Familial Hypercholesterolemia
YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company's in vivo genome editing candidate being develope...
April 03, 2024 | News
Innovent and HUTCHMED's Endometrial Cancer Therapy Receives Priority Review by China's NMPA
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
April 03, 2024 | News
Alebund Pharmaceuticals Receives FDA Orphan Drug Designation for AP303 in ADPKD Treatment
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for th...
April 01, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
- Eva van Pelt Joins Qiagen's Supervisory Board, Bringing a Wealth of Global Leadership Experience in Healthcare and Life Sciences
- Life Sciences Queensland Welcomes Dr. Kym Baker and Dr. Denise Hodge to Board Leadership
- Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division
- Danaher Careers - Search Global Science and Technology Jobs
- Careers at MERCK Group
- Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility
- Veranova Appoints Mike Riley as Chief Executive Officer
- Find your Job at Eppendorf
News
Editor Picks
